Spotify Surges on AI Music Collaboration with Universal Music Group and Updated Outlook HALO Stocks Emerge as AIResistant Investment Theme New ETF Launches to Capitalize SP 500 Extends Gains as Healthcare and Tech Lead Broad Advance Amazon Expands AI Shopping Technology to ThirdParty Retailers Signs Kate Spade as First Customer Bloom Energy Surges 12 on 26 Billion Partnership with European AI Infrastructure Firm Nebius Former Google Employee Charged with Insider Trading Using Internal Data NHI Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds ALAB Q1 2026 Earnings EPS Beats Estimates Revenue Not Disclosed RAPP Q1 2026 Earnings Narrower Loss Beats Street Estimates as PreRevenue Biotech Advances Pipeline Mitsubishi UFJ Financial Group MUFG Q1 2026 Earnings Strong EPS Beat Driven by Higher Net Interest Income Orthofix Medical Inc OFIX Q1 2026 Earnings Significant EPS Beat Drives Stock Rally INUV Q1 2026 Earnings EPS Surprises to the Upside with 17081 Beat Tower Semiconductor TSEM Edges Higher as Semiconductor Sector Shows Resilience RGC Resources RGCO Edges Higher Amid Tight Trading Range Virtus AI Tech Opportunities Fund AIO Edges Higher Testing Resistance as Sector Sentiment Improves Manchester United Shares Slip Amid Performance Concerns BayCom Corp BCML Edges Higher Amid Quiet Trading Holds Above Key Support China Signals It Is Open to a Deal Keeping TikTok in US L3Harris Q1 2026 Earnings EPS Beat Drives Positive Market Response Despite Limited Revenue Disclosure GJR Holds Steady at 2475 STRATS Trust Maintains Ground Amid Low Volume ABM Q1 2026 Earnings EPS Misses Estimates Despite Operational Progress Prosperity Bancshares PB Q1 2026 Earnings EPS Misses Estimates Amid Margin Pressure SBLK Q1 2026 Earnings Strong EPS Beat Amid Dry Bulk Headwinds Cheche Group CCG Q4 2024 Earnings EPS Beats Estimates by 4012 Revenue Not Reported AMT Q1 2026 Earnings EPS Surges Past Estimates with 1363 Beat CLS Q1 2026 Earnings Beat and Raise as Celestica Delivers Strong EPS Surprise CLDI Q4 2025 Earnings Significant EPS Beat Amid Ongoing Clinical Development